These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8132)

  • 1. The effect of beta-adrenergic blocking agents on experimental porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in vivo and in vitro.
    Schoenfeld N; Epstein O; Atsmon A
    Biochim Biophys Acta; 1976 Aug; 444(1):286-93. PubMed ID: 8132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria.
    Blum I; Schoenfeld N; Atsmon A
    Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental latent and acute porphyria in the non-fasted rat; preventive effect of propranolol.
    Schoenfeld N; Mamet R; Mevasser R; Atsmon A
    Scand J Clin Lab Invest; 1991 Dec; 51(8):667-73. PubMed ID: 1806982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice.
    De Matteis F; Abbritti G; Gibbs AH
    Biochem J; 1973 Jul; 134(3):717-27. PubMed ID: 4749272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of experimental porphyria with colchicine.
    Wysenbeek AJ; Schoenfeld N; Epstein O; Greenblat Y; Atsmon A
    Int J Biochem; 1985; 17(8):937-40. PubMed ID: 4043513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the effects of certain drugs on experimental porphyria in rats.
    Deshpande SG; Kandhari KC; Narang BS; Bikhchandani R; Bhutani LK
    Dermatologica; 1977; 154(5):284-90. PubMed ID: 863070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferro-lyase.
    Tephly TR; Gibbs AH; De Matteis F
    Biochem J; 1979 Apr; 180(1):241-4. PubMed ID: 486100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of certain anaesthetic agents for their ability to elicit acute porphyric phases in susceptible patients.
    Blekkenhorst GH; Harrison GG; Cook ES; Eales L
    Br J Anaesth; 1980 Aug; 52(8):759-62. PubMed ID: 7426253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Glucose effect" and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias.
    Doss M; Sixel-Dietrich F; Verspohl F
    J Clin Chem Clin Biochem; 1985 Sep; 23(9):505-13. PubMed ID: 4067519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of liver 5-aminolaevulinate synthetase by drugs and its relevance to drug-induced accumulation of cytochrome P-450. Studies with phenylbutazone and 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
    De Matteis F; Gibbs A
    Biochem J; 1972 Mar; 126(5):1149-60. PubMed ID: 5073727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver.
    Cole SP; Zelt DT; Marks GS
    Mol Pharmacol; 1981 May; 19(3):477-80. PubMed ID: 7266472
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-Diethoxycarbonyl-1,4-dihydrocollidine and related drugs: evidence for two basically different mechanisms.
    De Matteis F; Gibbs AH
    Biochem J; 1975 Jan; 146(1):285-7. PubMed ID: 1147902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The porphyrinogenic effect of simvastatin in experimental systems.
    Schoenfeld N; Mamet R; Lurie Y; Green P; Bomstein Y; Atsmon A
    Biomed Pharmacother; 1989; 43(2):135-9. PubMed ID: 2736273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria-inducing activity of a series of pyridine and dihydropyridine compounds. Investigation in a cell culture system.
    Roomi MW
    J Med Chem; 1975 May; 18(5):457-60. PubMed ID: 1151957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the porphyrinogenic compounds hexachlorobenzene and 3,5-diethoxycarbonyl-1,4-dihydrocollidine on polyamine metabolism.
    Cochón AC; González N; San Martín de Viale LC
    Toxicology; 2002 Jul; 176(3):209-19. PubMed ID: 12093617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1, 4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
    Cole SP; Whitney RA; Marks GS
    Mol Pharmacol; 1981 Sep; 20(2):395-403. PubMed ID: 7300820
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of desferrioxamine and chronic iron deficiency of heme metabolism--comparison with the porphyrogens 2-allyl-2-isopropylacetamide and 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
    Liem H; Smith A; Muller-Eberhard U
    Biochem Pharmacol; 1979 Jun; 28(11):1753-8. PubMed ID: 475836
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of clonidine in a primed rat model of acute hepatic porphyria.
    Goerz G; Bolsen K; Böhrer H; Fritsch C; Kalka K; Rominger KL
    Arzneimittelforschung; 1997 Jun; 47(6):731-3. PubMed ID: 9239451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced porphyrin biosynthesis--XIX. Potentiation of the porphyrin-inducing effects of SKF 525-A in the chick embryo liver by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine, an antihibitor of ferrochelatase.
    Cole SP; Vavasour EJ; Marks GS
    Biochem Pharmacol; 1979 Dec; 28(24):0533-8. PubMed ID: 533555
    [No Abstract]   [Full Text] [Related]  

  • 20. PK 11195 aggravates 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced hepatic porphyria in rats.
    Fonia O; Weizman R; Coleman R; Kaganovskaya E; Gavish M
    Hepatology; 1996 Sep; 24(3):697-701. PubMed ID: 8781345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.